Figure 4 from 3D “Emboli” Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis

Read full text Summarise with VIRAT
Authors: Kuppusamy Balamurugan, Melissa R. Mikolaj, Jonathan M. Weiss, Ronald J. Holewinski, Yu Fan, Shiba Prasad Dash, Xia Xu, Lois McKennett, Christopher W. Dell, Duncan E. Donohue, Ariana Vitale, Shashikala Ratnayake
+7 more Shikha Sharan, Qingrong Chen, Daoud M. Meerzaman, Þorkell Andrésson, Daniel W. McVicar, Kedar Narayan, Esta Sterneck
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

EmC renders cells sensitive to ETC inhibitors and protected from oxidative stress. A, FC in the numbers of viable SUM149, IBC-3, and MDA-MB-468 cells in EmC and SphC after 72 hours of treatment with OXPHOS inhibitor IACS-010579, added at the indicated concentrations to the established cultures. DMSO was used as a vehicle control (n = 3). B, FC in the numbers of viable SUM149, IBC-3, and MDA-MB-468 cells in EmC and SphC after 72 hours of treatment with DCA, added at the indicated concentrations to the established cultures. DMSO was used as a vehicle control (n = 3). C, FCs in the numbers of viable SUM149, IBC-3, and MDA-MB-468 in EmC and SphC after 72 hours of treatment with FX-11, added at the indicated concentrations to the established cultures. DMSO was used as a vehicle control (n = 3). D, Quantification of ROS by DCF fluorescence measurements in SUM149 and IBC-3 cells from the indicated culture conditions. H202 (100 μmol/L) was added to the dissociated cells 15 minutes prior to analysis (n = 3, mean ± SEM). E, FC in the numbers of viable SUM149 and IBC-3 cells as in C after 2 hours of exposure to H202. Data are expressed as mean ± SEM, *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001); n.s., not significant.

Fields of Study & Subjects

Cancer Hypoxia and Metabolism Cancer Cells and Metastasis Mitochondrial Function and Pathology

Publication details

Publication date
19 March 2026
Language
EN